Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

dsm-firmenich Ventures

Profile and portfolio

Parent dsm-firmenichHQ Maastricht, NetherlandsFounded 2001

dsm-firmenich Ventures is the corporate venture arm of dsm-firmenich, a chemicals and materials company. It was founded in 2001 and is based in Maastricht, Netherlands. It invests from seed to growth. Sectors it names: healthcare and digital health, food and agriculture, consumer and retail.

Companies backedS1
100+

Every figure links to its source

Snapshot

Investment stage: Seed to Growth
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Growth
SectorsHealthcare and digital health, Food and agriculture, Consumer and retail, Sector agnostic
GeographyNorth America, Europe
OfficesMaastricht, Netherlands

Sources: S1 dsm-firmenich Ventures.

Graphic 1 of 3

Investment stage: Seed to Growth

Sources: S1 dsm-firmenich Ventures.

Download:Report a correction
Investments closed by outcome
Data behind this graphic
Data behind this graphic
ItemCompaniesShare
Active3375%
Exited1125%

Status as the firm tags it

Sources: S3 dsm-firmenich Ventures: Our portfolio.

Graphic 2 of 3

Investments closed by outcome

Sources: S3 dsm-firmenich Ventures: Our portfolio.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Companies backed100+companiesStated by the firmS1
Companies on the firm's portfolio page44companiesCounted from the firm's own listS3

Sources: S1 dsm-firmenich Ventures; S3 dsm-firmenich Ventures: Our portfolio.

Graphic 3 of 3

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 dsm-firmenich Ventures; S3 dsm-firmenich Ventures: Our portfolio.

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Maastricht, Netherlands
Offices
  • Maastricht, Netherlands

Investment regionsS1

LeadersS2

dsm-firmenich Ventures on LinkedIn

Key facts

FactValueStatusSource
Parent companydsm-firmenichSingle sourceS1
Parent industryChemicals and materialsSingle sourceS1
Founded2001Single sourceS1
HeadquartersMaastricht, NetherlandsSingle sourceS8
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Companies backed100+Single sourceS1
People on the team page10Single sourceS2
StagesSeed, GrowthSingle sourceS1

For founders

ItemWhat the firm saysSource
StagesSeed, GrowthS1
Check sizeEUR 500,000 to EUR 5MS1
Leads roundsSometimesS1
Beyond capitalBoard-level involvement and access to dsm-firmenich scientific, technological and commercial resourcesS1

Portfolio

The firm's portfolio page lists 44 companies: 33 active, 11 exited.S3

The firm also states 100+ companies backed. The page list and the stated total measure different things.S1

Companies by status on the firm's list. Status as the firm tags itS3
TagCompaniesShare
Active3375%
Exited1125%

Shared portfolio with other corporate VCs

12 companies on the dsm-firmenich Ventures portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Ajinomoto Group Ventures2Athian, Enhanced Medical Nutrition
Rich Products Ventures2Chinova Bioworks, Phytolon
Cargill Ventures1AnimalBiome
R/GA Ventures1AnimalBiome
Cultivate Next1Athian
GC Ventures1Inkbit
Zeon Ventures1Inkbit
Applied Ventures1Adaptive3D
UH Ventures1CollaMedix
Future Back Ventures1Nous
Beiersdorf Venture Capital1S-Biomedic
Ki Tua Fund1Sun Genomics

Companies backed by the most corporate VCs

Every company on the dsm-firmenich Ventures list

44 companies, as listed on the firm's own website: 33 active, 11 exited.S3 Read the firm's list.

Active 33

  • Aavia
  • Additive Manufacturing Technologies
  • Animal Biome
  • Athian
  • Atro Medical
  • Chinova Bioworks
  • Chromatic 3d Materials
  • CollaMedix
  • Cybele Microbiome
  • Cynomys
  • Enhanced Medical Nutrition
  • Frontier Nutrition
  • Hyalex Orthopaedics
  • Incredo
  • Inkbit
  • Inne by Feral
  • Java Foods
  • Life Boost
  • Meala
  • Meatly
  • Miach Orthopaedics
  • NC Biomatrix
  • Nous
  • NutriLeads
  • Octarine
  • Paleo
  • Phynova
  • Phytolon
  • Ripple Therapeutics
  • Rootine
  • Sun Genomics
  • VitaminLab
  • Vivici

Exited 11

  • Adaptive 3D
  • Arecor
  • Chromadex
  • Essential Medical
  • EyePromise
  • Isobionics
  • Momentous
  • Natreon
  • Ok Capsule
  • S-biomedic
  • Voxel8

Recent rounds

DateCompanyRoundAmountSource
2026-05-26Cosaic AGSeedUSD 6MS5
2026-05-26P2 ScienceGrowthUSD 23MS6

History

  1. First venture investments (site: since 2001 invested in more than 100 startups).S1
  2. Integrated Annual Report 2025: investments in two startups, P2 Sciences and ExoLab; focus on opportunities with a horizon of two years or more.S4

Official pages

Read the firm's own pages for current information.

  • Website our-company.dsm-firmenich.com/en/our-company/ventures.html
  • Portfolio our-company.dsm-firmenich.com/en/our-company/ventures/portfolio.html

Sources

  1. S1dsm-firmenich VenturesFirm
  2. S2dsm-firmenich Ventures: Our teamFirm
  3. S3dsm-firmenich Ventures: Our portfolioFirm
  4. S4dsm-firmenich Integrated Annual Report 2025Filing
  5. S5MLL Legal: advised DSM Venturing B.V. on Cosaic AG late seed roundThird-party report
  6. S6PR Newswire: P2 Science closes $23 Million RoundPortfolio company
  7. S7dsm-firmenich Ventures: Scott HornerFirm
  8. S8dsm-firmenich Our locations (dual headquarters Maastricht, Wilhelminasingel 39)Parent company

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by dsm-firmenich Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.